Learning Objectives

As a result of participating in this activity, learners will be better able/better-able to:

predict synergistic responses of drug interactions
consider the increased likelihood of DME-related adverse-events, related to off-label medication usage, when devising treatment plans with patients
verify the safety procedures in place at compounding pharmacies

Accreditation & Designation

Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Neurovations Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes discussions of unlabeled or investigational uses of commercial and/or developmental products.

Disclosure of Financial Relationships

Neither the presenters, reviewers nor any other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, any financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.